Omo Clement, Ph.D., Senior Product Manager of Sequencing at RainDance Technologies discussed ThunderBolts NGS Gene Panels for Mutational Analysis of Solid Tumors and Heme Disorders at the 2015 RainDance User Group Meeting.
Kimberly Helzer, Senior Market Development Application Scientist of RainDance Technologies discussed Enabling Custom Targeted NGS Panels with ThunderBolts Open Source at the 2015 RainDance User Group Meeting.
In this video, Dr. John A. Martignetti of Icahn School of Medicine at Mount Sinai, shares his experience with the RainDrop Digital PCR System. His work was also featured in an ASCOpost: “Liquid Biopsies Predict Treatment Response and Survival in Gynecologic Cancers”.
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.